Embed presentation
Download to read offline































This document summarizes research comparing selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT) for treating glaucoma. SLT uses lower energy "cold laser" technology, resulting in less thermal damage to trabecular meshwork cells and architecture compared to ALT. Precise targeting is not required for SLT. SLT typically does not cause endothelial membrane formation, crater formation, coagulative damage, or disruption of trabecular beams and endothelial cells like ALT can. Clinical studies have found similar IOP decreases of around 20% for both SLT and ALT. The document also briefly describes new laser and endoscopic cyclophotocoagulation procedures for glaucoma treatment.





























